Efeito antidepressivo da riparina III em camundongos submetidos ao modelo de estresse induzido pela administração de corticosterona

• Ano de defesa: 2015
• Autor(a) principal: Vasconcelos, Auriana Serra
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Palavras-chave em Português: Corticosterona; Depressão; Sintomas Comportamentais; Fator Neurotrófico Derivado do Encéfalo
• Link de acesso: http://www.repositorio.ufc.br/handle/riufc/13931

Major depression is a common disorder of severe mood swings, chronic and recurrent. It’s believed that the etiology resulting from abnormalities which interact with environmental and genetic factors, and environmental stress main factor described. The riparina III (Rip III), isolated from the green fruit of Aniba riparia is a bioactive compound that has had action on the central nervous system, with anxiolytic and antidepressant activity. Therefore, the objective of this study is to investigate the antidepressant potential of Rip III in mice subjected to stress model induced by the administration of corticosterone (Cort) in preventing and reversing protocols. Swiss female mice were used. To assess the reversal, each animal received a subcutaneous injection (sc) Cort 20mg / kg or vehicle for 22 days. From the 14th day of treatment onwards, the animals received oral administration respectively vehicle, Rip III or fluvoxamine (Flu) for eight days. Behavioral tests were recorded on 14, 15, 21 and 22 days of treatment. The preventive treatment occurred in a 14-day interval and the final behavioral tests were performed. Then the animals were sacrificed and dissected hippocampal BDNF and dosage. The results showed that it was possible to induce depression with corticosterone and Rip III and Flu were able to reverse and prevent behavioral changes in the forced swimming test, tail suspension, anhedonia, plus maze, open field, social interaction and, only in reverse memory test and prepulso inhibition without changing locomotor activity. Further, restored BDNF levels in the hippocampus. Therefore, this study also has shown that Rip III is an effective drug in reversing and preventing this model. Thus, this study opens the possibility for continuity in order to elucidate the pathways with which it is involved, contributing as another possible drug with potential for use in treating depression.